Resultsbee.com

10042 Garvey Ave,El Monte,CA

(162) 627 - 9656

200 Medical Plaza Driveway Suite 22-442 MDCC,Los Angeles,CA

James D. Cherry, MD, MSc is a Distinguished Research Professor at the David Geffen School of Medicine at UCLA and UCLA Mattel Children's Hospital, Division of Infectious Diseases. Dr. Chery received his MD degree from the University of Vermont in 1957 and his MSc degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983. He received his pediatric residency training at Boston City Hospital and Kings County Hospital and his infectious diseases fellowship training at the Thorndike Memorial Laboratory, Harvard Medical Service at Boston City Hospital. Following his infectious diseases fellowship training, Dr. Cherry established one of the first formal pediatric infectious disease fellowship programs in the world in 1963 at the University of Wisconsin. In 1973 Dr. Cherry started the first pediatric infectious training program at UCLA. During his 47 years tenure at UCLA, numerous trainees have gone on to be leaders in pediatric infectious diseases in the United States and other countries throughout the world. In 1969-70, Dr. Cherry was a visiting worker at the Medical Research Council, Common Cold Research Unit and Clinical Research Centre, Salisbury, England. From 1989 to 1996, Dr. Cherry and associates carried out an extensive pertussis vaccine efficiency trail in Erlanger, Germany. In 2000-2001, he was a visiting scholar in the Department of Clinical Veterinary Medicine, University of Cambridge, England. In addition, Dr. Cherry was the director of a vaccine reaction study in Denmark at a participant in two USAID nutrition/immunology projects in Kenya. Throughout his career, Dr. Cherry has received numerous national and international awards. Some of these include: The John and Mary B. Markle Scholar in Academic Medicine; Distinguished Physician Award of the Pediatric Infectious Diseases Society; The Stanley A. Plotkin Lectureship in Vaccinology of the Pediatric Infectious Diseases Society; The European Society for Pediatric Infectious Diseases Bill Marshall Award; The American Academy of Pediatrics Section on Infectious Diseases Award for Lifetime Contribution to Infectious Diseases Education; and The UCLA, Edward A. Dickson Emeritus Professorship Award. Dr. Cherry has published 323 research papers, 109 editorials and commentaries and 303 book chapters. He is the senior editor of Feigin and Cherry's Textbook of Pediatric Infectious Disease, which is now in its 8th edition. Dr. Cherry's laboratory experience involved virology, mycoplasmology, serology, and molecular microbiology. His main research over the last 57 years has been related to vaccines and vaccine preventable diseases (measles, rubella, influenza, smallpox, and pertussis). A major interest since 1976 relates to pertussis epidemiology and pertussis vaccines. Over the last 10 years, he and colleagues at the California Department of Public Health and California pediatric infectious diseases physicians have been studying severe pertussis in young infants. Another area of interest has been measles and measles vaccines. He and colleagues first described secondary measles vaccine failure in 1972 in Saint Louis and more recently in California. He presently is involved in measles related studies in the Democratic Republic of the Congo and in Switzerland. Finally, he has been involved in Zika virus studies in Brazil.

(131) 082 - 5522

200 Medical Plaza Driveway Suite 265,Los Angeles,CA

Grace M. Aldrovandi, MD CM, is a physician-scientist and Chief of the Division of Infectious Diseases at UCLA Mattel Children’s Hospital and a Professor of Pediatrics at the David Geffen School of Medicine of the University of California, Los Angeles. Dr. Aldrovandi is a board-certified pediatric infectious diseases specialist with over 20 years experience in caring for both general pediatric infectious diseases as well as HIV infected children and their families. Dr. Aldrovandi’s research interests include pediatric HIV, the effects of breast milk on child health and infections in immunocompromised children. She has published more than 100 peer review publications in such journals as Nature, Journal of Virology, and the New England Journal of Medicine and multiple book chapters. She has been a member of multiple National Institutes of Health study sections and lectured throughout the world. She also was invited by the National Institutes of Health (NIH) to serve as a member of the AIDS Immunology and Pathogenesis Study Section of the Center for Scientific Review. As a researcher, Dr. Aldrovandi has chaired national and international studies on HIV pathogenesis within the International Maternal, Pediatric and Adolescent AIDS Clinical Trials Network (IMPAACT) and the Adolescent Trials Network (ATN). She was elected Chair of the IMPAACT Laboratory Committee, where she provides scientific leadership and quality assurance/quality control programs for all the laboratories (Virology, Immunology, Pharmacology and Genetics). Dr. Aldrovandi was recently selected to Chair the AIDS Clinical Trials Group (ACTG) Laboratory Center in addition where she performs similar duties. She is the former Chair of the Pediatric AIDS Clinical Trials Group (PACTG) Virology Committee and a member of the phenotypic and genotypic resistance working groups as well as the dried blood spot swat team. She is also a member of the Genotypic Advisory Committee of the NIAID VQA to establish a DAIDS quality assurance program for genotypic analysis of drug resistance mutations. She has considerable scientific expertise in pediatric HIV, basic HIV virology, HIV clinical assays and HIV drug resistance. Dr. Aldrovandi has been awarded the prestigious Elizabeth Glaser Scientist Award for her work on breast milk transmission of HIV-1. More recently, Dr. Aldrovandi has investigated the role of the microbiome in normal infant development, how the microbiome is perturbed by HIV-1, and how the microbiome affects HIV-1 susceptibility at mucosal sites. Her initial interest in the microbiome developed from her studies of breast milk and breast milk transmission of HIV-1. Mother’s actively excrete bacteria and special proteins, human milk oligosaccharides, thought to support the commensal bacterial, to their infants via breast milk. Certain immune cells in the infant gut do not develop until the cells receive signals from the commensal bacteria. It is this complex interplay between mother, infant and microbe that Dr. Aldrovandi is trying to understand through many of her microbiome studies. Additionally, her investigations have expanded to improve the understanding of the microbiome in HIV susceptibility and its role in human disease and treatment response. Dr. Aldrovandi received two bachelor’s degrees and her medical degree from McGill University in Montreal, Canada. She completed an internship and residency at McGill, as well as a research fellowship in pediatric infectious diseases at the University of California, Los Angeles.

(131) 082 - 5086

10833 Le Conte Ave. Suite 13-188 CHS,Los Angeles,CA

Michael Teitell received B.S. and M.S. degrees from the UCLA College Honors Program as a Departmental Scholar in Chemistry and Biochemistry in 1985. He earned combined M.D. and Ph.D. degrees in the UCLA Medical Scientist Training Program in 1993. His graduate and early post-doctoral studies were with Dr. Mitchell Kronenberg at UCLA in Molecular and Cellular Immunology. Dr. Teitell was a Resident and Clinical Instructor in Anatomic Pathology at Brigham and Women's Hospital and Harvard Medical School from 1993-1995. During this time he was a Research Associate with Dr. Richard Blumberg. From 1995-1997, Dr. Teitell was a Resident in Clinical Pathology at UCSF and a post-doctoral researcher with Dr. Joe Gray. From 1997-1999, he held a joint appointment at Children's Hospital of Los Angeles as a Pediatric Pathology Fellow and at UCLA as a Clinical Instructor in Pathology. He became an Assistant Professor in the UCLA Department of Pathology and Laboratory Medicine in 1999. He was jointly appointed in the UCLA Department of Pediatrics in 2001 and was promoted to Associate Professor with tenure in 2004. He currently serves as Chief of the Division of Pediatric and Developmental Pathology, with board certification in anatomic, clinical and pediatric pathology. Dr. Teitell has received several important honors and awards. Among these are the David Paul Kane Scholar Award of the Jonsson Cancer Center Foundation (2000-2001), the Lymphoma Research Foundation Junior Faculty Award (2001-2002), the FOCIS/Millenium Pharmaceuticals Young Investigator Award in Genomics Research (2001-2002), a Scholar Award from the Leukemia and Lymphoma Society (2003-2008), election to the American Society of Clinical Investigators (2004) and a Margaret E. Early Medical Research Trust Award (2005). Education and Training 1981-1985 UCLA. B.S., M.S. - Chemistry and Biochemistry 1985-1993 UCLA. M.D., Ph.D. - Molecular Immunology and Medicine Research, Professional Experience and Professional Positions 1991-1993 Post-doctoral Fellow, Microbiology and Immunology, UCLA 1993-1995 Clinical Instructor and Resident, Anatomic Pathology, Harvard Medical School 1994-1995 Research Associate, Medicine, Brigham and Women's Hospital 1995-1997 Resident, Clinical Pathology, UCSF 1997-1999 Fellow, Pediatric Pathology, Children's Hospital, Los Angeles 1999-2004 Assistant Professor, Departments of Pathology and Pediatrics, UCLA 2004-2008 Associate Professor, Departments of Pathology and Pediatrics, UCLA 2008-present Professor, Departments of Pathology and Pediatrics, UCLA Professional Activities 1995-present American Association of Immunologists, Abul Abbas (sponsor) 1999-present Member of the Molecular Biology Institute, UCLA 1999-present Member of the Jonsson Comprehensive Cancer Center, UCLA 2002-present American Society for Biochem and Molec Biology, Joan Conaway (sponsor) 2003-present Medical Scientist Training Program, Executive Committee, UCLA 2004-present American Association for Cancer Research, Richard Gatti (sponsor) 2004-present NIH, Cancer Genetics Study Section Member 2005-present Member, California NanoSystems Institute (CNSI) 2005-present Member, Broad Center for Stem Cell Research (ISCBM), UCLA 2006-present Member, Epigenetics Society 2006-present American Society for Microbiology 2006-present Section Editor, Laboratory Investigation 2006-present Editorial Board, Nanomedicine 2006-present Consulting Editor, Editorial Board, Pediatric Research 2007-present Member, Biophysical Society, Robert Callender (sponsor) 2007 Judge, College Board, Siemens Comp. in Math, Science & Technology, National Finals, NYU 2008-2009 Chair, Intercollegiate Athletics Committee, UCLA 2008 Chair, California Cancer Research Coordinating Committee 2008 Chair, Oncogenic & Tumor Suppressor Pathways, AACR Annual Meeting

(131) 082 - 5894

100 Medical Plaza Drive Suite 755,Los Angeles,CA

ABOUT DR. THOMAS KREMEN, MD As a board-certified orthopedic surgeon with additional subspecialty certification in Sports Medicine, Thomas J. Kremen, MD has devoted his career to helping patients of all sports levels maintain active lifestyles. Using the latest orthopedic techniques and science, Dr. Kremen helps athletes in Los Angeles recover quickly from injury, getting them back into the game stronger than ever. From shoulder problems to debilitating knee injuries, Dr. Kremen understands the added stresses that active lifestyles place on the human musculoskeletal system. His goal is to not only help his patients overcome their injuries, but also provide solid preventive care to avoid re-injury down the road. In his role as a sports medicine specialist, Dr. Kremen has served as team physician for organizations around the country, and around the world, helping athletes across the globe stay at the top of their game. He has served as team physician for numerous organizations including Duke University Intercollegiate Athletics, US Mens National Team Soccer, LA Galaxy, LA Football Club, and USA Swimming. He currently serves as a team physician for the UCLA Bruins NCAA Division I intercollegiate athletics team and as the chair of USA Swimmings Sports Medicine and Science Committee. Dr. Kremen earned his bachelors degree from the University of California, Santa Barbara in 1998 where he was also captain of the NCAA Division I mens swimming team. He earned his medical degree from the David Geffen School of Medicine at the University of California Los Angeles (UCLA) in 2006 and then continued at UCLA where he completed his Orthopedic Surgery Residency Training in 2012. Between 2008 and 2009, Dr. Kremen honed his research knowledge as a California Institute for Regenerative Medicine Clinical Fellow and in 2013, he completed an Orthopedic Sports Medicine and Shoulder Surgery fellowship at Duke University in Durham, North Carolina. Dr. Kremen stays up to date in his field through memberships in the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society, the Arthroscopy Association of North America, and the American Orthopaedic Society for Sports Medicine, to name just a few. In his pursuit of finding the best treatments, Dr. Kremen regularly participates in research studies, and he has authored and presented dozens of research papers. His research interests include biomechanical studies of shoulder and knee reconstruction procedures as well as innovative biologic therapies to enhance tissue regeneration after musculoskeletal injuries. Dr. Kremen is currently a full-time faculty member at the University of California, Los Angeles where he provides his patients with state-of-the-art care.      

(131) 095 - 7334